About the role
Company Overview:
Prime Medicine is a leading biotechnology company dedicated to creating and delivering the next generation of gene editing therapies to patients. The Company is leveraging its proprietary Prime Editing platform, a versatile, precise and efficient gene editing technology, to develop a new class of differentiated, one-time, potentially curative genetic therapies. Designed to make only the right edit at the right position within a gene while minimizing unwanted DNA modifications, Prime Editors have the potential to repair almost all types of genetic mutations and work in many different tissues, organs and cell types.
Prime Medicine is currently progressing a diversified portfolio of investigational therapeutic programs organized around our core areas of focus: hematology, immunology & oncology, liver and lung. Across each core area, Prime Medicine is focused initially on a set of high value programs, each targeting a disease with well-understood biology and a clearly defined clinical development and regulatory path, and each expected to provide the foundation for expansion into additional opportunities. For more information, please visit www.primemedicine.com.
The pay range reflects the full-time base salary range we expect to pay for this role at the time of posting. Base pay will be determined based on several factors including, but not limited to, relevant experience, skills, and education. This role is eligible for an annual short-term incentive award (e.g., bonus) and an annual long-term incentive award (e.g., equity).
Prime Medicine offers a comprehensive Total Rewards package with robust health, financial, and wellness benefits—including medical, dental, vision, life insurance, a 401(k) match, and equity programs—along with generous paid time off, wellness days, and company-wide recharge breaks.
Our commitment to employee well-being reflects our belief that when we care for our people, we strengthen our ability to put patients first and make meaningful impact together.
Prime Medicine is proud to be an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, national origin, age, sexual orientation, gender identity, disability, veteran status, or any other classification protected by law.
Aplyr's read
Prime Medicine is pioneering gene-editing technologies with a focus on precision and safety, attracting scientists and innovators passionate about transforming healthcare.
What's promising
- •Prime Medicine is at the forefront of gene-editing technology, offering cutting-edge solutions in healthcare.
- •The company has attracted top talent in AI and informatics, enhancing its research capabilities.
- •Prime Medicine's focus on safety assessment and DMPK highlights its commitment to drug safety and efficacy.
What to watch
- •The gene-editing field is highly competitive, posing challenges for Prime Medicine to maintain its market position.
- •Regulatory hurdles in gene-editing can delay product development and market entry.
- •Limited public information about the company's financial stability and long-term viability.
Why Prime Medicine
- •Prime Medicine's emphasis on precision gene-editing sets it apart in the biotechnology sector.
- •The integration of AI in their research processes enhances the accuracy and efficiency of their scientific endeavors.
- •A strong focus on culture and people development is evident with roles like Director, People and Culture Business Partner.
Aplyr’s read is generated by AI from public sources. Was it useful?